Patients with cirrhosis and ascites have false values of bone density Implications for the diagnosis of osteoporosis

Osteoporosis International

Volumn 23, Issue 4, 2012, Pages 1481-1487

  Guanabens N ^a,b,d   Monegal, A ^a   Muxi, A ^a   Martinez Ferrer, A ^a   Reyes, R ^a   Caballeria J ^a,b   Del Rio L ^c   Peris, P ^a,b   Pons, F ^a   Pares A ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CETIR Centre Medic   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Densitometry; Liver disease; Liver transplantation; Osteopenia; Paracentesis

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HUMAN; HYPOVOLEMIA; LEAN BODY WEIGHT; LIVER CIRRHOSIS; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; PARACENTESIS; PRIORITY JOURNAL; ARTIFACT; FEMUR NECK; HIP; LABORATORY DIAGNOSIS; LUMBAR VERTEBRA; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PROSPECTIVE STUDY;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; ARTIFACTS; ASCITES; BONE DENSITY; FALSE POSITIVE REACTIONS; FEMALE; FEMUR NECK; HIP JOINT; HUMANS; LIVER CIRRHOSIS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PARACENTESIS; PROSPECTIVE STUDIES;

EID: 84861720252     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1756-1     Document Type: Article

References (29)

1. Guañabens N, Pares A (2010) Liver and bone. Arch Biochem Biophys 503:84-94
2. Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ et al (1997) Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60:148-154
3. Cohen A, Sambrook P, Shane E (2004) Management of bone loss after organ transplantation. J Bone Miner Res 19:1919-1932
4. Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ et al (2001) Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12:484-492
5. Leidig-Bruckner G, Hosch S, Dodidou P, Ritschel D, Conradt C, Klose C et al (2001) Frequency and predictors of osteoporotic fractures after cardiac and liver transplantation: a follow-up study. Lancet 357:342-347
6. Adams J, Bishop N (2008) DXA in adults and children. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism,7th ed. Washington DC, pp. 152-158
7. Bolotin HH (2007) DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. Bone 41:138-54
8. Tothill P, Hannan WJ, Cowen S, Freeman CP (1997) Anomalies in the measurement of changes in total body bone mineral by dual-energy x-ray absorptiometry during weight change. J Bone Miner Res 12:1908-1921
9. Tothill P, Avenell A (1994) Errors in dual-energy x-ray absorptiometry of the lumbar spine owing to fat distribution and soft tissue thickness during weight change. Br J Radiol 67:71-75
10. Jensen LB, Quaade F, Sorensen OH (1994) Bone loss accompanying voluntary weight loss in obese humans. J Bone Miner Res 9:459-463
11. Woodrow G, Oldroyd B, Turney JH, Smith MA (1996) Influence of changes in peritoneal fluid on body-composition measurements by dual-energy x-ray absorptiometry in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr 64:237-241
12. Labio ED, Del Rosario DB, Strasser SI, McCaughan GW, Crawford BA (2007) Effect of ascites on bone density measurements in cirrhosis. J Clin Densitom 10:391-394
13. Haderslev KV, Svendsen OL, Staun M (1999) Does paracentesis of ascites influence measurements of bone mineral or body composition by dual-energy x-ray absorptiometry? Metabolism 48:373-377
14. Hannon R, Blumsohn A, Naylor K, Eastell R (1998) Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res 13:1124-1133
15. Ninkovic M, Love SA, Tom B, Alexander GJM, Compston JE (2001) High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 69:321-326
16. American Gastroenterological Association Medical Position Statement: Osteoporosis in hepatic disorders (2003) Gastroenterology 125:937-940
17. Ninkovic M, Love SA, Tom BD, Bearcroft PW, Alexander GJ, Compston JE (2002) Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotropic liver transplantation. J Hepatol 37:93-100
18. Crawford BAL, Kam CK, Pavlovic J, Byth K, Handelsman DJ, Angus PW et al (2006) Zoledronic acid prevents bone loss after liver transplantation. A randomized, double-blind, placebocontrolled trial. Ann Intern Med 144:239-248
19. Monegal A, Guañabens N, Suárez MJ, Suárez F, Clemente G, García-González M et al (2009) Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial. Transplant Int 22:198-206
20. Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH et al (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437-1443
21. Miller PD, McClung MR, Macovei L, Stakkestad JA, Luckey M, Bonvoisin B et al (2005) Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res 20:1315-1322
22. Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U et al (2002) Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653-661
23. McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH et al (2006) Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 354:821-831
24. Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW et al (1991) Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296-300
25. Pietrobelli A, Wang Z, Formica C, Heymsfield SB (1998) Dualenergy x-ray absorptiometry. Fat estimation errors due to variation in soft tissue hydration. Am J Physiol Endocrinol Metab 274:808-816
26. Peng S, Plank LD, McCall JL, Gillanders LK, Mcllroy K, Gane EJ (2007) Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 85:1257-1266
27. Vilarrasa N, Gómez JM, Elio I, Gómez-Vaquero C, Masdevall C, Pujol J et al (2009) Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg 19:860-866
28. Levitt DG, Beckman LM, Mager JR, Valentine B, Sibley SD, Beckman TR et al (2010) Comparison of DXA and water measurements of body fat following gastric bypass surgery and a physiological model of body water, fat and muscle composition. J Appl Physiol 109:786-795
29. Uusi-Rasi K, Sievänen H, Kannus P, Pasanen M, Kukkonen-Harjula K, Folgelholm M (2009) Influence of weight reduction on muscle performance and bone mass, structure and metabolism in obese premenopausal women. J Musculoskelet Neuronal Interact 9:72-80